Bowel Cancer good news
Just received this notiication I thought might be of interest to those of you who may have a loved one who is suffering from Bowel Cancer
Immix Biopharma Says Colorectal Cancer Combination Therapy Reduced Tumor Size in Clinical Trial
Date May 03, 2023 Time 10:41 AM
Source MT Newswires
Immix Biopharma (IMMX) said Wednesday that combining its IMX-110 drug with BeiGene (BGNE) and Novartis' (NVS) tislelizumab antibody reduced tumor size in advanced metastatic colorectal cancer, based on early interim data from its dose-escalation clinical trial.
The combination therapy showed a 100% reduction in tumor size at two months in the first group of patients who received the lowest IMX-110 dose, the company said, adding that there were no dose-limiting toxicities observed.
The company said the trial can now enroll the next group of three patients at a higher dose of IMX-110 combined with tislelizumab.
Immix Biopharma were down more than 18% in recent trading, BeiGene shares were off 0.1%, and Novartis shares added 0.4%.
Price: 2.37, Change: -0.53, Percent Change: -18.28
http://www.mtnewswires.com
Copyright © 2023 MT Newswires. All rights reserved. MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
Market data, news, and company information provided by Interactive Data. Copyright © 2016. Terms of use. Earnings estimates and analyst ratings provided by Zacks. News provided by The Associated Press and MT Newswires, a division of MidnightTrader, Inc. Hemscott equity data provided by Morningstar, Inc. Analyst reports provided by Argus Research Company and Marketgrader.com. Share details provided by EDGAR Online. Economic events copyright 1999-2016 Econoday, Inc. Earnings events provided by Wall Street Horizon. © 2016 Wall Street Horizon, Inc.
Glossary
Interested in more discussions like this? Go to the Cancer Support Group.
This announcement is more a news release from a company whose revenues are derived from a drug it sells. That is it's targeted at the investing, not scientific, community. So caveat emptor and, as with any "news release" like this, due diligence is the word to the wise. That's not to say that they're not developing a drug that may turn out to be profoundly important but it's based on research the compamy paid for and needs to be looked at with a slightly jaundiced eye. I say this as someone who worked on Wall Street and read thousands of these things and had to filter them for investors to identify the information of value.
I would add that a statistical sample of three is an inordinately tiny universe from which two derive anything of real value. But again that's geared to investors not the scientific community, which would dismiss a sample of three as well.
I admit I do not have your knowledge of Wall Street, or the workings of Scientific Communities that you are familiar with. But I do know what it is like when you are waiting and hoping for that Scientific Break through that will bring a special blessing to the patient. Any news of hope, is welcome and perhaps this will be the one. It is hard to messure how much hope this one News Releaase may bring to someone who is waiting. Thank you for your caring and advice.
Gina5009
I agree with you and sincerely hope that I didn't inadvertently sound dismissive of any breakthrough. As a cancer survivor, I read a lot of research studies trying to find the gold nuggets that might be important one day…
Thank you folr yout kind reply. I also know that never ending research that goes on, in every cancer survivors head. My husband had prostate cancer, and then lung cancer which he did not survive, and I have been fortunate enough to survive breast cancer at 36, a dematofibrosarcoma in 1988, and now MCUS, but I also have been fortunate enough to know, it is God's will not mine that wins out in the end. But that does not stop me from reading every piece of "hope" I find, and thinking this may be the answer for someone out there. Many years ago, when I worked for a Doctor, I saw a patient who came in with what everyone thought was a fatty tumor in his arm pit. He decided to have it removed because it was uncomfortable. It was found to be a lymphosarcoma and he was told he probably had about one year to live. He struggled through that year with very little hope. At the end of the year, he still seemed to be in good health and it was decided to take out the slides and take another look, because it must have been misdiagnosed. The diagnosis was still the same, and to my knowledge that man is still in good health. How can that be?? Hope, Love, Belief, all powerful medicines. There is an answer for you, and you will find it, keep looking.
Gina5009